The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if gevokizumab therapy may be an alternate therapy
in patients with steroid resistant Autoimmune Inner Ear Disease.
Phase:
Phase 2
Details
Lead Sponsor:
XOMA (US) LLC
Collaborators:
Feinstein Institute for Medical Research National Institute on Deafness and Other Communication Disorders (NIDCD)